82 results
Page 2 of 5
8-K
EX-99.1
w4a9xo9yh6lln t2
28 Apr 11
Key R&D Milestones and Strong Financials
12:00am
8-K
EX-99.1
icvz261tpm
27 Jan 11
Receives U.S. Regulatory Approval for KOMBIGLYZE™ XR, and First-Line Indication for SPRYCEL® in Fourth Quarter
12:00am
8-K
EX-10.14
75vd02ew4x
17 Aug 09
Other Events
12:00am
8-K
EX-10.12
qszho3qnjgfk91
17 Aug 09
Other Events
12:00am
8-K
EX-99.1
gyzh79i3
28 Apr 09
Management’s Discussion and Analysis of Financial Condition and Results of Operations
12:00am
424B5
c0o3chg
17 Nov 06
Prospectus supplement for primary offering
12:00am